Key facts
- This page summarizes Juan Andres's Form 3 filing for Moderna, Inc. (MRNA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Oct 2026, 18:27.
Juan Andres - 05 Oct 2026 Form 3 Insider Report for Moderna, Inc. (MRNA)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- MRNA
- Reported as of
- 05 Oct 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 05 Oct 2026, 18:27:02 UTC
- Prior SEC filing
- 12 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ James Dillon, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Juan Andres filed Form 3 for Moderna, Inc. (MRNA) on 05 Oct 2026.
Change
- Previous filing in this sequence was filed on 12 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001760670
Primary reporting owner
Andres Juan
- Relationship
- Chief Operating Officer
- Address
- C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE
- Signature
- /s/ James Dillon, as Attorney-in-Fact
- Signature date
- 05 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRNA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 125,000
- Date
- 05 Oct 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.